LCD for Steroid Injections (L1664)

 

Contractor Information

Contractor Name 

BlueCross BlueShield of Tennessee (Riverbend Government Benefits Administrator) 

Contractor Number 

00390 

Contractor Type 

FI 

 

LCD Information

LCD ID Number 

L1664 

 

LCD Title 

Steroid Injections 

 

Contractor's Determination Number 

1664 

 

AMA CPT / ADA CDT Copyright Statement 

CPT codes, descriptions and other data only are copyright 2007 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.  

 

CMS National Coverage Policy 

Title XVIII of the Social Security Act, Section 1862 (a)(1)(A). This section excludes coverage of items or services that are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Title XVIII of the Social Security Act, Section 1862 (a)(7). This section prohibits Medicare payment for any expenses on items and services incurred for routine physical examinations.

Title XVIII of the Social Security Act, Section 1833 (e). This section prohibits Medicare payment for any claim that lacks the necessary information to process the claim.
 

 

Primary Geographic Jurisdiction 

New Jersey
Tennessee
 

 

Secondary Geographic Jurisdiction 

Alaska
Alabama
Arkansas
Arizona
California
Colorado
Connecticut
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
North Carolina
North Dakota
Nebraska
New Jersey
New Mexico
Nevada
New York
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
 

 

Oversight Region 

Region IV
 

 

 

Original Determination Effective Date 

For services performed on or after 12/27/1996  

 

Original Determination Ending Date 

 

 

Revision Effective Date 

For services performed on or after 07/27/2005  

 

Revision Ending Date 

 

 

Indications and Limitations of Coverage and/or Medical Necessity 

Intermuscular steroid injections for treatment of specific symptoms, illnesses, or injury, when oral therapy is not feasible.(not for intravenous use)

Medicare will only provide coverage for IM steroid injections that are medically necessary based on specific symptoms, illnesses or injuries. Medical necessity includes:


1. Specific symptomatology requiring immediate relief of the medical condition (i.e. shortness of breath, inspiration or expiratory wheezing, skin condition causing extreme itching, severe joint discomfort, unrelieved by NSAID or oral steroid, which requires a joint injection)

2. Contraindicatives are present which may make treatment of choice intramuscular injections (i.e. stomach upset producing nausea and/or vomiting, history of gastric conditions).

 

 

Coverage Topic 

Prescription Drugs
 

 

Coding Information

Bill Type Codes: 

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

13x

Hospital-outpatient (HHA-A also) (under OPPS 13X must be used for ASC claims submitted for OPPS payment -- eff. 7/00)

14x

Non-Patient Laboratory Specimens

21x

SNF-inpatient, Part A

22x

SNF-inpatient or home health visits (Part B only)

23x

SNF-outpatient (HHA-A also)

71x

Clinic-rural health

72x

Clinic-hospital based or independent renal dialysis facility

75x

Clinic-CORF

 

 

Revenue Codes: 

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

 

0636

Drugs requiring specific identification-detailed coding (eff 3/92)

 

 

CPT/HCPCS Codes 

 

J1100

INJECTION, DEXAMETHASONE SODIUM PHOSPHATE, 1MG

 

 

ICD-9 Codes that Support Medical Necessity 

 

053.20

HERPES ZOSTER DERMATITIS OF EYELID

124

TRICHINOSIS

135

SARCOIDOSIS

200.00 - 208.91*

RETICULOSARCOMA UNSPECIFIED SITE - UNSPECIFIED LEUKEMIA IN REMISSION

245.0

ACUTE THYROIDITIS

255.2

ADRENOGENITAL DISORDERS

275.42

HYPERCALCEMIA

283.0 - 283.9

AUTOIMMUNE HEMOLYTIC ANEMIAS - ACQUIRED HEMOLYTIC ANEMIA UNSPECIFIED

284.01 - 284.89

CONSTITUTIONAL RED BLOOD CELL APLASIA - OTHER SPECIFIED APLASTIC ANEMIAS

287.4

SECONDARY THROMBOCYTOPENIA

351.0 - 351.9

BELL'S PALSY - FACIAL NERVE DISORDER UNSPECIFIED

360.11

SYMPATHETIC UVEITIS

363.10 - 363.15

DISSEMINATED CHORIORETINITIS UNSPECIFIED - DISSEMINATED RETINITIS AND RETINOCHOROIDITIS PIGMENT EPITHELIOPATHY

363.20

CHORIORETINITIS UNSPECIFIED

364.00 - 364.9*

ACUTE AND SUBACUTE IRIDOCYCLITIS UNSPECIFIED - UNSPECIFIED DISORDER OF IRIS AND CILIARY BODY

370.00 - 370.9

CORNEAL ULCER UNSPECIFIED - UNSPECIFIED KERATITIS

372.05 - 372.14

ACUTE ATOPIC CONJUNCTIVITIS - OTHER CHRONIC ALLERGIC CONJUNCTIVITIS

377.30

OPTIC NEURITIS UNSPECIFIED

380.00

PERICHONDRITIS OF PINNA UNSPECIFIED

380.14

MALIGNANT OTITIS EXTERNA

386.00 - 386.03

MENIERE'S DISEASE UNSPECIFIED - ACTIVE MENIERE'S DISEASE VESTIBULAR

386.30 - 386.35

LABYRINTHITIS UNSPECIFIED - VIRAL LABYRINTHITIS

388.2

SUDDEN HEARING LOSS UNSPECIFIED

461.0 - 461.9

ACUTE MAXILLARY SINUSITIS - ACUTE SINUSITIS UNSPECIFIED

462

ACUTE PHARYNGITIS

463

ACUTE TONSILLITIS

464.11

ACUTE TRACHEITIS WITH OBSTRUCTION

464.21

ACUTE LARYNGOTRACHEITIS WITH OBSTRUCTION

464.30 - 464.31

ACUTE EPIGLOTTITIS WITHOUT OBSTRUCTION - ACUTE EPIGLOTTITIS WITH OBSTRUCTION

465.9

ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE

466.0

ACUTE BRONCHITIS

471.0 - 471.9

POLYP OF NASAL CAVITY - UNSPECIFIED NASAL POLYP

472.0

CHRONIC RHINITIS

474.11

HYPERTROPHY OF TONSILS ALONE

477.9

ALLERGIC RHINITIS CAUSE UNSPECIFIED

478.0

HYPERTROPHY OF NASAL TURBINATES

478.25

EDEMA OF PHARYNX OR NASOPHARYNX

478.6

EDEMA OF LARYNX

493.01

EXTRINSIC ASTHMA WITH STATUS ASTHMATICUS

493.11

INTRINSIC ASTHMA WITH STATUS ASTHMATICUS

493.21

CHRONIC OBSTRUCTIVE ASTHMA WITH STATUS ASTHMATICUS

493.91

ASTHMA UNSPECIFIED TYPE WITH STATUS ASTHMATICUS

690.10 - 690.12

SEBORRHEIC DERMATITIS UNSPECIFIED - SEBORRHEIC INFANTILE DERMATITIS

691.8

OTHER ATOPIC DERMATITIS AND RELATED CONDITIONS

692.0 - 692.79

CONTACT DERMATITIS AND OTHER ECZEMA DUE TO DETERGENTS - OTHER DERMATITIS DUE TO SOLAR RADIATION

692.81 - 692.9

DERMATITIS DUE TO COSMETICS - CONTACT DERMATITIS AND OTHER ECZEMA UNSPECIFIED CAUSE

693.0 - 693.9

DERMATITIS DUE TO DRUGS AND MEDICINES TAKEN INTERNALLY - DERMATITIS DUE TO UNSPECIFIED SUBSTANCE TAKEN INTERNALLY

694.0 - 694.5

DERMATITIS HERPETIFORMIS - PEMPHIGOID

694.60 - 694.61

BENIGN MUCOUS MEMBRANE PEMPHIGOID WITHOUT OCULAR INVOLVEMENT - BENIGN MUCOUS MEMBRANE PEMPHIGOID WITH OCULAR INVOLVEMENT

694.8

OTHER SPECIFIED BULLOUS DERMATOSES

694.9

UNSPECIFIED BULLOUS DERMATOSES

695.1

ERYTHEMA MULTIFORME

695.4

LUPUS ERYTHEMATOSUS

695.81 - 695.89

RITTER'S DISEASE - OTHER SPECIFIED ERYTHEMATOUS CONDITIONS

696.0

PSORIATIC ARTHROPATHY

696.1

OTHER PSORIASIS AND SIMILAR DISORDERS

697.0

LICHEN PLANUS

698.3

LICHENIFICATION AND LICHEN SIMPLEX CHRONICUS

701.4

KELOID SCAR

704.01

ALOPECIA AREATA

708.8

OTHER SPECIFIED URTICARIA

709.3

DEGENERATIVE SKIN DISORDERS

710.0

SYSTEMIC LUPUS ERYTHEMATOSUS

714.0 - 714.33

RHEUMATOID ARTHRITIS - MONOARTICULAR JUVENILE RHEUMATOID ARTHRITIS

715.00

OSTEOARTHROSIS GENERALIZED INVOLVING UNSPECIFIED SITE

716.10

TRAUMATIC ARTHROPATHY SITE UNSPECIFIED

716.98

UNSPECIFIED ARTHROPATHY INVOLVING OTHER SPECIFIED SITES

719.00 - 719.99

EFFUSION OF JOINT SITE UNSPECIFIED - UNSPECIFIED JOINT DISORDER OF MULTIPLE SITES

720.0

ANKYLOSING SPONDYLITIS

726.0 - 726.91

ADHESIVE CAPSULITIS OF SHOULDER - EXOSTOSIS OF UNSPECIFIED SITE

727.00 - 727.09

SYNOVITIS AND TENOSYNOVITIS UNSPECIFIED - OTHER SYNOVITIS AND TENOSYNOVITIS

727.42

GANGLION OF TENDON SHEATH

787.01

NAUSEA WITH VOMITING

787.02

NAUSEA ALONE

787.03

VOMITING ALONE

791.0

PROTEINURIA

995.20 - 995.3

UNSPECIFIED ADVERSE EFFECT OF UNSPECIFIED DRUG, MEDICINAL AND BIOLOGICAL SUBSTANCE - ALLERGY UNSPECIFIED NOT ELSEWHERE CLASSIFIED

999.5

OTHER SERUM REACTION NOT ELSEWHERE CLASSIFIED

999.8

OTHER TRANSFUSION REACTION NOT ELSEWHERE CLASSIFIED

V58.11

ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY

V58.12

ENCOUNTER FOR IMMUNOTHERAPY FOR NEOPLASTIC CONDITION

* latest code update

 

 

Diagnoses that Support Medical Necessity 

 

 

ICD-9 Codes that DO NOT Support Medical Necessity 

 

 

 

 

ICD-9 Codes that DO NOT Support Medical Necessity Asterisk Explanation 

 

 

Diagnoses that DO NOT Support Medical Necessity 

 

 

General Information

Documentation Requirements 

Medical documentation for all intramuscular steroid injections, which are covered by Medicare, is expected to indicate the medical necessity within the patients medical records, should a review become necessary. Documentation supporting the medical necessity of this item, such as ICD-9-CM codes, must be submitted when requested. If documentation is requested, submit:

 

  • M.D. orders/progress notes
  • Drug administration record
  • Itemization of charges

 

 

Appendices 

 

 

Utilization Guidelines 

 

 

Sources of Information and Basis for Decision 

Carrier Policy

Medical texts

PDR physicains’ desk reference-2003 

 

Advisory Committee Meeting Notes 

This policy does not reflect the sole opinion of the contractor or contractor medical director. Although the final decision rests with the contractor, this policy was developed in cooperation with advisory groups, which includes representatives from appropriate specialties as well as provider (facility) representatives. 

 

Start Date of Comment Period 

 

 

End Date of Comment Period 

 

 

Start Date of Notice Period 

11/27/1996 

 

Revision History Number 

1664a 

 

Revision History Explanation 

10/01/2004 Annual ICD-9 Code Update: Inserted 692.84 in ICD-9 Codes that Support Medical Necessity.

07/24/2002 Formatted

11/8/2000 updated ICD-9 codes to be compatible with ICD-9 Code book 2001, & HCPCS code book

01/29/2005 - CPT/HCPCS code J1095 was deleted from group 1

This LCD was converted from an LMRP on 7/26/2005

09/04/2005 - This policy was updated by the ICD-9 2005-2006 Annual Update.

7/2/2006 - The description for Bill code 14 was changed

09/04/2006 - This policy was updated by the ICD-9 2006-2007 Annual Update.

09/03/2007 - This policy was updated by the ICD-9 2007-2008 Annual Update.

09/28/2007 - Frequently Asked Questions restored to Appendices.

2/18/2008 - The description for Bill code 21 was changed

04/03/2008 - Frequently Asked Questions removed from Appendices as link could not be restored 

 

Reason for Change 

Other
 

Last Reviewed On Date 

04/03/2008 

 

Related Documents 

Article(s)
A35159 - Steroid Injections

 

LCD Attachments 

FAQ - Comment and Response (958 bytes)

 

Other Versions 

Updated on 02/18/2008 with effective dates 07/27/2005 - N/A

Updated on 09/28/2007 with effective dates 07/27/2005 - N/A

Updated on 09/05/2006 with effective dates 07/27/2005 - N/A

Updated on 07/02/2006 with effective dates 07/27/2005 - N/A

Updated on 09/19/2005 with effective dates 07/27/2005 - N/A

Updated on 07/26/2005 with effective dates 07/27/2005 - N/A

Updated on 07/26/2005 with effective dates 01/01/2005 - 07/26/2005

Updated on 11/19/2004 with effective dates 10/01/2004 - 12/31/2004

Updated on 09/15/2004 with effective dates 07/24/2002 - 09/30/2004

Updated on 09/08/2004 with effective dates 07/24/2002 - N/A

Updated on 10/09/2003 with effective dates 07/24/2002 - N/A

Updated on 09/08/2003 with effective dates 07/24/2002 - N/A

Updated on 03/11/2003 with effective dates 07/24/2002 - N/A

Updated on 10/04/2002 with effective dates 07/24/2002 - N/A